Dr.Vasa General Hospital.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.00 M
as on 24-10-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.23 Cr
as on 24-10-2024
- Revenue 7.79%
(FY 2023)
- Profit -2.53%
(FY 2023)
- Ebitda -77.42%
(FY 2023)
- Net Worth 10.66%
(FY 2023)
- Total Assets 21.42%
(FY 2023)
About Dr.Vasa General Hospital.Ltd.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹11.23 Cr.
Rakhi Agarwal and Sandeep Agarwal serve as directors at the Company.
- CIN/LLPIN
U85110MH1993PTC072711
- Company No.
072711
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr.Vasa General Hospital.Ltd.?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Agarwal  | Director | 16-May-2008 | Current |
| Rakhi Agarwal | Director | 16-May-2008 | Current |
Financial Performance of Dr.Vasa General Hospital.Ltd..
Dr.Vasa General Hospital Pvt.Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 7.79% increase. The company also saw a slight decrease in profitability, with a 2.53% decrease in profit. The company's net worth Soared by an impressive increase of 10.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Vasa General Hospital.Ltd.?
In 2023, Dr.Vasa General Hospital.Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Exicom Technologies India Private LimitedActive 1 year 6 monthsRakhi Agarwal and Sandeep Agarwal are mutual person
Monique Gems Exports Private LimitedActive 27 years 3 monthsRakhi Agarwal and Sandeep Agarwal are mutual person
- Brij Habitats Private LimitedActive 11 years 9 months
Rakhi Agarwal and Sandeep Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Nov 2022 | ₹6.23 Cr | Open |
Capital First Limited Creation Date: 05 Dec 2014 | ₹5.00 Cr | Open |
How Many Employees Work at Dr.Vasa General Hospital.Ltd.?
Unlock and access historical data on people associated with Dr.Vasa General Hospital.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Vasa General Hospital.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Vasa General Hospital.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
